Showing results (111-120 of 186) with videos related to
Sort By:
Pageof 19
Clinical and Experimental Immunology|August 26, 1998
The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responsesK F Hu, M Elvander, M Merza, et al.Journal of Virology|March 14, 1998
A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assemblyM A Accola, S Höglund, H G GöttlingerScandinavian Journal of Clinical and Laboratory Investigation|December 1, 1976
Preparation of cross-linked human serum albumin labelled with 125I for studies of reticuloendothelial system functionL Berghem, L Dencker, S Höglund, et al.Journal of Virology|February 7, 2001
Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutationA Cimarelli, S Sandin, S Höglund, et al.Journal of Virology|March 9, 2000
Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNAA Cimarelli, S Sandin, S Höglund, et al.Journal of Virology|March 1, 1990
Epstein-Barr virus (EBV) antigens processed and presented by B cells, B blasts, and macrophages trigger T-cell-mediated inhibition of EBV-induced B-cell transformationM T Bejarano, M G Masucci, A Morgan, et al.Nature|April 26, 1990
Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMsH Takahashi, T Takeshita, B Morein, et al.Vaccine|April 9, 1999
The major Epstein-Barr virus (EBV) envelope glycoprotein gp340 when incorporated into Iscoms primes cytotoxic T-cell responses directed against EBV lymphoblastoid cell linesA D Wilson, K Lövgren-Bengtsson, M Villacres-Ericsson, et al.Veterinary Microbiology|June 16, 1997
Assessment of the immunogenic potential of Rhodococcus equi virulence associated protein (VapA) in miceJ F Prescott, M C Patterson, V M Nicholson, et al.Vaccine|April 1, 1989
Serological responses in cats vaccinated with FeLV ISCOM and an inactivated FeLV vaccineA Osterhaus, K Weijer, F UytdeHaag, et al.Pageof 19